Mettler-Toledo International (NYSE:MTD) Coverage Initiated at The Goldman Sachs Group

Investment analysts at The Goldman Sachs Group assumed coverage on shares of Mettler-Toledo International (NYSE:MTD) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The firm set a “neutral” rating and a $1,475.00 price target on the medical instruments supplier’s stock. The Goldman Sachs Group’s price target would suggest a potential upside of 5.01% from the stock’s current price.

A number of other equities analysts have also recently issued reports on the stock. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Citigroup upped their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Stifel Nicolaus increased their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Finally, Bank of America boosted their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,424.17.

Mettler-Toledo International Trading Up 2.4%

MTD stock opened at $1,404.68 on Tuesday. The stock’s 50 day simple moving average is $1,398.11 and its 200 day simple moving average is $1,289.21. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,525.17. The firm has a market cap of $28.70 billion, a P/E ratio of 35.03, a P/E/G ratio of 4.43 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The company had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. During the same period in the prior year, the company earned $10.21 earnings per share. The firm’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of the business’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director directly owned 311 shares in the company, valued at approximately $445,840.27. The trade was a 60.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total transaction of $1,511,000.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,990,168. The trade was a 15.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,565 shares of company stock worth $28,683,737 in the last three months. Insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MTD. Versant Capital Management Inc grew its stake in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares in the last quarter. SJS Investment Consulting Inc. boosted its holdings in shares of Mettler-Toledo International by 2,700.0% during the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 27 shares during the period. Salomon & Ludwin LLC purchased a new position in Mettler-Toledo International during the third quarter valued at approximately $43,000. Root Financial Partners LLC acquired a new position in Mettler-Toledo International in the 3rd quarter valued at approximately $42,000. Finally, WPG Advisers LLC purchased a new stake in Mettler-Toledo International in the 1st quarter worth approximately $41,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.